AzTrials
AzTrials

Cortical ExcitabilityNCT07588113

rTMS Induced Reduction in M1 Excitability

A study testing rTMS in people with Cortical Excitability and Primary Motor Cortex, run by Indiana University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

When learning a new skill, much of the improvement comes from small alterations the brain makes with each repetition during practice, but this isn't the only time that improvements are made during the learning process. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
What is being tested?
rTMS
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
1 siteUnited States
Study dates
23 Apr 2026to 23 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Between ages 18 and 45 years old (to avoid any changes in the developing brain, or with aging).
  • Answer 'no' to questions 2 through 17 on the brain stimulation questionnaire as these factors can increase likelihood of adverse events with brain stimulation.
  • No neurological damage, disease, or dysfunction (nerve damage, chronic pain disorders, diabetic neuropathy, epilepsy) that affect the upper limbs and limit the ability to complete the study, and/or compromise the objectives of the study
  • No significant visual impairment that would prevent them from playing a video game.

Who cannot join

  • Currently prescribed and taking stimulant medication (Adderall, Ritalin, Vyvanse, etc.)
  • Consumption of over-the-counter stimulants such as caffeine or nicotine (coffee, soda, supplements, energy drinks, tobacco products, or other nicotine containing products such as gum, vape pens, etc...) 12 hours prior to entering the lab on the day of testing as this can directly affect cortical excitability. If a subject takes any of these substances 12 hours prior to the study visit they will be asked to reschedule for a later date.
  • Have played a real stringed instrument in the last 12 months (e.g. guitar, bass, violin)
  • Have played the videogame "Guitar Hero" on a traditional guitar controller in the last 12 months.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zachary A Riley contact

317-274-1487

zariley@iu.edu

United States1 site, 1 recruiting
  • National Institute for Fitness and Sport

    Indianapolis, Indiana, 46202

    Zachary Riley, zariley@iu.edu

    Recruiting

Other trials in United States

About this study

Official title: The Effects of rTMS Induced Reduction in M1 Excitability on Early-online Learning and Retention in Dexterous Video-game Task

When learning a new skill, much of the improvement comes from small alterations the brain makes with each repetition during practice, but this isn't the only time that improvements are made during the learning process. Individuals also get better at the motor skills during the time between practices, through a process called "consolidation." It is known that an area of the brain called the primary motor cortex is involved in learning during active practice, but the investigators want to study if the primary motor cortex is important for consolidation. The investigators will examine how lowering the activity in this brain region affects your ability to consolidate learning to play a song on the videogame Guitar Hero.

Read the detailed description

Research employing rTMS-induced reductions in excitability showed that M1 had a large role in consolidation after practice, but was not responsible for the improvements that occur during practice. Though this study used a simple finger tapping task, additional studies have shown the role of M1 in task consolidation with ballistic movements and dynamic force-field learning tasks, while using rTMS to reduce cortical excitability. The main issue with previous studies is that they have been limited to a single digit, single joint, or non-transferrable laboratory tasks. This limits the application of these studies to real world scenarios, and shows the need for further research into this interaction. Therefore, we intend to examine the effect of an rTMS-induced reduction in M1 excitability, on the learning of a dynamic, two-handed video game task (Guitar Hero). This is important because it will help explain the role of M1 in learning complex, bimanual tasks. Our study will also directly address how M1 contributes to the fast and slow consolidation of dynamic, coordinated actions that more closely resemble real-world activities (video games). Ultimately, this knowledge is crucial to the development of targeted non-invasive brain stimulation protocols that could aid in the rehabilitation of patients with motor dysfunction, in which relearning complex coordinated motor tasks is a primary goal.

Objective(s)

  1. Primary Objective Our primary objective is to determine if short term inhibition of M1 with 1Hz rTMS (rTMS induced reductions in excitability) blocks the early online learning (fast and slow consolidation) that occurs when first playing a video game
  2. Secondary Objective Our secondary objective is to compare the amount of rTMS-induced reductions in excitability, measured with single pulse TMS motor-evoked potential cortical excitability, with the amount of fast and slow consolidation observed in playing the video game.
Being tested
rTMS
Keywords
Learning, Transcranial Magnetic Stimulation, Repetitive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rTMSDevice

    Also called Sham

    in the arm/group descriptions

Study groups in NCT07588113
Study groupRoleWhat they receive
rTMS stimulation groupExperimentalthis group will receive 15 minutes of repetitive transcranial magnetic stimulation of the motor cortex while seated quietly
Receives: Device: rTMS
SHAM stimulation groupPlacebo comparatorThis group will have the same stimulating wand placed over the head, but at a distance far enough away as to not activate the cortical neurons.
Receives: Device: rTMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gaming outcome

    Primary outcome measures will include comparing video game performance (number of correct notes played, overstrums) across the three testing sessions.

    Measured: 3 sessions, sessions 1 & 2 on the first day and session 3 on the follow-up day (next day)

Secondary outcomes (1)
  1. Cortical Changes

    Secondary outcome measures will include correlating cortical excitability with the amount of learning observed in video game performance.

    Measured: 3 sessions, sessions 1 & 2 on the first day and session 3 on the follow-up day (next day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2026
  2. Study start23 Apr 2026
  3. Primary completion23 Apr 2027 (estimated)
  4. Study completion23 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
2 groups- a stimulation group and a sham group that will be recruited and tested in parallel with one another.
Masking
Single blind
Who is masked
Participant
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07588113
Sponsor's protocol ID
30610
Status last verified
May 2026
First submitted
1 May 2026
Last updated
1 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: We do not plan to share study participant data

Questions about this trial

What is this clinical trial studying?

A study testing rTMS in people with Cortical Excitability and Primary Motor Cortex, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zachary A Riley (317-274-1487, zariley@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gaming outcome (time frame: 3 sessions, sessions 1 & 2 on the first day and session 3 on the follow-up day (next day)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in